{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T16:03:13Z","timestamp":1788624193506,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["oooojournal.net","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.oooo.2024.05.014","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T01:03:20Z","timestamp":1717463000000},"page":"475-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Medication-related osteonecrosis of the jaw (MRONJ) systemic review: mevalonate pathway mechanisms explored"],"prefix":"10.1016","volume":"138","author":[{"given":"Jungsuk","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Diecidue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.oooo.2024.05.014_bib0001","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw - 2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofacial Surg"},{"issue":"405","key":"10.1016\/j.oooo.2024.05.014_bib0002","first-page":"1","article-title":"Osteoporosis or low bone mass in older adults: United States, 2017-2018","author":"Sarafrazi","year":"2021","journal-title":"NCHS Data Brief"},{"issue":"2","key":"10.1016\/j.oooo.2024.05.014_bib0003","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/j.bjoms.2021.03.006","article-title":"Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: surgery or conservative therapy?","volume":"60","author":"Sacco","year":"2022","journal-title":"Br J Oral Maxillofacial Surg"},{"issue":"5 SUPPL","key":"10.1016\/j.oooo.2024.05.014_bib0004","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","article-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Carlson","year":"2009","journal-title":"J Oral Maxillofacial Surg"},{"issue":"2","key":"10.1016\/j.oooo.2024.05.014_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics10020195","article-title":"Conservative management of medication-related osteonecrosis of the jaws (MRONJ): a retrospective cohort study","volume":"10","author":"Varoni","year":"2021","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.oooo.2024.05.014_bib0006","doi-asserted-by":"crossref","first-page":"e684","DOI":"10.4317\/medoral.24007","article-title":"Medication related osteonecrosis of the jaws (MRONJ): factors related to recurrence after treatment with surgery and platelet rich plasma (PRP) placement","volume":"26","author":"Gallego-Albertos","year":"2021","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"352","key":"10.1016\/j.oooo.2024.05.014_bib0007","first-page":"1","article-title":"Biologic and pathologic aspects of osteocytes in the setting of medication-related osteonecrosis of the jaw (MRONJ)","volume":"153","author":"Aguirre","year":"2021","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.oooo.2024.05.014_bib0008","doi-asserted-by":"crossref","first-page":"e03795","DOI":"10.1016\/j.heliyon.2020.e03795","article-title":"Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): a systematic review","volume":"6","author":"Ottesen","year":"2020","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.oooo.2024.05.014_bib0009","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.oooo.2024.05.014_bib0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1759720X13477714","article-title":"Bisphosphonate drug holiday: who, when and how long","volume":"5","author":"Diab","year":"2013","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"8","key":"10.1016\/j.oooo.2024.05.014_bib0011","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/01.OGX.0000134304.25332.EF","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"59","author":"Bone","year":"2004","journal-title":"Obstet Gynecol Surv"},{"issue":"5","key":"10.1016\/j.oooo.2024.05.014_bib0012","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws\u20142022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofacial Surg"},{"issue":"5","key":"10.1016\/j.oooo.2024.05.014_bib0013","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.oooo.2018.02.003","article-title":"Medication-related osteonecrosis of the jaw: an update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention","volume":"125","author":"Owosho","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"6","key":"10.1016\/j.oooo.2024.05.014_bib0014","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11914-022-00756-5","article-title":"Osteoclast recycling and the rebound phenomenon following denosumab discontinuation","volume":"20","author":"Kim","year":"2022","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"10.1016\/j.oooo.2024.05.014_bib0015","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF) \u2013 key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Rom J Morphol Embryol"},{"issue":"1","key":"10.1016\/j.oooo.2024.05.014_bib0016","article-title":"Vascular endothelial growth factor inhibitor-induced hypertension: basics for primary care providers","volume":"1","author":"Escalante","year":"2011","journal-title":"Cardiol Res Pract"},{"issue":"6","key":"10.1016\/j.oooo.2024.05.014_bib0017","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1016\/j.oooo.2017.09.005","article-title":"Methotrexate-associated osteonecrosis of the jaw: a report of two cases","volume":"124","author":"Henien","year":"2017","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2024.05.014_bib0018","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.12659\/AJCR.905355","article-title":"A case of osteonecrosis of the jaw in a patient with Crohn's disease treated with infliximab","volume":"18","author":"Favia","year":"2017","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.oooo.2024.05.014_bib0019","article-title":"Tocilizumab: another medication related to osteonecrosis of the jaws? A case report and literature review","volume":"10","author":"Sakkas","year":"2021"},{"issue":"3","key":"10.1016\/j.oooo.2024.05.014_bib0020","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jormas.2019.06.009","article-title":"Rituximab as a trigger factor of medication-related osteonecrosis of the jaw. A case report","volume":"121","author":"Javelot","year":"2020","journal-title":"J Stomatol Oral Maxillofac Surg"},{"issue":"12","key":"10.1016\/j.oooo.2024.05.014_bib0021","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/annonc\/mdm370","article-title":"A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients","volume":"18","author":"Jadu","year":"2007","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.oooo.2024.05.014_bib0022","first-page":"138","article-title":"Biphosphonates-associated osteonecrosis of the jaw: the role of gene-environment interaction","volume":"54","author":"Izzotti","year":"2013","journal-title":"J Prev Med Hyg"},{"issue":"4","key":"10.1016\/j.oooo.2024.05.014_bib0023","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/sj.bdj.2018.132","article-title":"Pharmacology: MRONJ risk factor","volume":"224","author":"Patel","year":"2018","journal-title":"Br Dent J"},{"issue":"4","key":"10.1016\/j.oooo.2024.05.014_bib0024","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1620\/tjem.246.257","article-title":"Risk of delayed healing of tooth extraction wounds and osteonecrosis of the jaw among patients treated with potential immunosuppressive drugs: A retrospective cohort study","volume":"246","author":"Hayashi","year":"2019","journal-title":"Tohoku J Exp Med"},{"issue":"3","key":"10.1016\/j.oooo.2024.05.014_bib0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2165\/00003088-199630030-00002","article-title":"Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis","volume":"30","author":"Bannwarth","year":"1996","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"10.1016\/j.oooo.2024.05.014_bib0026","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s40262-017-0627-0","article-title":"Clinical pharmacokinetics and pharmacodynamics of infliximab in the treatment of inflammatory bowel disease","volume":"57","author":"Hemperly","year":"2018","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.oooo.2024.05.014_bib0027","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40262-021-01092-0","article-title":"Pharmacokinetic\/pharmacodynamic considerations of alternate dosing strategies of tocilizumab in COVID-19","volume":"61","author":"Leung","year":"2022","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.oooo.2024.05.014_bib0028","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/bcp.14102","article-title":"CD4+ count-dependent concentration\u2013effect relationship of rituximab in rheumatoid arthritis","volume":"85","author":"Bensalem","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.oooo.2024.05.014_bib0029","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bone.2015.08.012","article-title":"Animal model for medication-related osteonecrosis of the jaw with precedent metabolic bone disease","volume":"81","author":"Kim","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.oooo.2024.05.014_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.842845","article-title":"A mouse periodontitis model with humanized oral bacterial community","volume":"12","author":"Bai","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"10.1016\/j.oooo.2024.05.014_bib0031","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jcms.2017.07.002","article-title":"Further development of the MRONJ minipig large animal model","volume":"45","author":"Otto","year":"2017","journal-title":"J Craniomaxillofacial Surg"},{"issue":"1","key":"10.1016\/j.oooo.2024.05.014_bib0032","doi-asserted-by":"crossref","DOI":"10.1038\/s41368-022-00182-4","article-title":"Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)","volume":"14","author":"Yan","year":"2022","journal-title":"Int J Oral Sci"},{"issue":"2","key":"10.1016\/j.oooo.2024.05.014_bib0033","first-page":"235","article-title":"Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates","volume":"296","author":"Dunford","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.oooo.2024.05.014_bib0034","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.joms.2021.08.074","article-title":"Development of a cause-based treatment for NBP-induced MRONJ","volume":"79","author":"Young","year":"2021","journal-title":"J Oral and Maxillofacial Surg"},{"issue":"6","key":"10.1016\/j.oooo.2024.05.014_bib0035","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.joms.2020.01.009","article-title":"Medication-related osteonecrosis of the jaw in patients taking high-dose simvastatin","volume":"78","author":"Giladi","year":"2020","journal-title":"J Oral Maxillofacial Surg"},{"issue":"AUG","key":"10.1016\/j.oooo.2024.05.014_bib0036","first-page":"1","article-title":"Defective protein prenylation in a spectrum of patients with mevalonate kinase deficiency","volume":"10","author":"Munoz","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.oooo.2024.05.014_bib0037","first-page":"364","article-title":"Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw","volume":"3","author":"Marini","year":"2011","journal-title":"Front Biosci (Elite Ed)"},{"issue":"2","key":"10.1016\/j.oooo.2024.05.014_bib0038","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jbmr.4185","article-title":"SIRT1 gene SNP rs932658 is associated with medication-related osteonecrosis of the jaw","volume":"36","author":"Yang","year":"2021","journal-title":"J Bone Mineral Res"},{"key":"10.1016\/j.oooo.2024.05.014_bib0039","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1402.089","article-title":"Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy","volume":"1117","author":"Russell","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"10.1016\/j.oooo.2024.05.014_bib0040","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/odi.12513","article-title":"Immune cellular profile of bisphosphonate-related osteonecrosis of the jaw","volume":"22","author":"de Barros Silva","year":"2016","journal-title":"Oral Dis"},{"issue":"67","key":"10.1016\/j.oooo.2024.05.014_bib0041","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1248\/bpb.b16-01020","article-title":"Underlying mechanisms and therapeutic strategies for bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"40","author":"Endo","year":"2017","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.oooo.2024.05.014_bib0042","doi-asserted-by":"crossref","first-page":"44245","DOI":"10.1038\/srep44245","article-title":"Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells","volume":"7","author":"Tai","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.oooo.2024.05.014_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-91248-6","article-title":"Denosumab versus romosozumab for postmenopausal osteoporosis treatment","volume":"11","author":"Kobayakawa","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.oooo.2024.05.014_bib0044","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11914-017-0356-1","article-title":"T Regulatory cells in bone remodelling","volume":"15","author":"Bozec","year":"2017","journal-title":"Curr Osteoporos Rep"},{"issue":"9","key":"10.1016\/j.oooo.2024.05.014_bib0045","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.jcms.2019.06.004","article-title":"Gingival fibroblasts and medication-related osteonecrosis of the jaw: results by real-time and wound healing in vitro assays","volume":"47","author":"Yuan","year":"2019","journal-title":"J Craniomaxillofacial Surg"},{"issue":"12","key":"10.1016\/j.oooo.2024.05.014_bib0046","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-13-0042","article-title":"IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws","volume":"19","author":"Shi","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.oooo.2024.05.014_bib0047","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/jop.12640","article-title":"Chronic treatment with zoledronic acid increases inflammatory markers in periodontium of rats","volume":"46","author":"de Barros Silva","year":"2017","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"10.1016\/j.oooo.2024.05.014_bib0048","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12903-023-03034-7","article-title":"Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Oral Health"},{"issue":"2","key":"10.1016\/j.oooo.2024.05.014_bib0049","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cyto.2014.10.025","article-title":"The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells","volume":"71","author":"Ishtiaq","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.oooo.2024.05.014_bib0050","article-title":"Early changes of VEGF Levels after zoledronic acid in women with postmenopausal osteoporosis: a potential role of vitamin D","volume":"8","author":"Bellone","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"10.1016\/j.oooo.2024.05.014_bib0051","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.matbio.2008.06.005","article-title":"VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and \u03b23-integrin","volume":"27","author":"Yang","year":"2008","journal-title":"Matrix Biol"},{"issue":"9","key":"10.1016\/j.oooo.2024.05.014_bib0052","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00109-013-1049-6","article-title":"Mitochondrial UQCRB regulates VEGFR2 signaling in endothelial cells","volume":"91","author":"Jung","year":"2013","journal-title":"J Mol Med"},{"issue":"11","key":"10.1016\/j.oooo.2024.05.014_bib0053","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrendo.2011.108","article-title":"Parathyroid hormone analogues in the treatment of osteoporosis","volume":"7","author":"Kraenzlin","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"10.1016\/j.oooo.2024.05.014_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220712","article-title":"Metabolomic profiling reveals salivary hypotaurine as a potential early detection marker for medication-related osteonecrosis of the jaw","volume":"14","author":"Yatsuoka","year":"2019","journal-title":"PLoS One"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440324003171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440324003171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T23:40:50Z","timestamp":1724802050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440324003171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2212440324003171"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2024.05.014","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication-related osteonecrosis of the jaw (MRONJ) systemic review: mevalonate pathway mechanisms explored","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2024.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}